Shinjuro Namiki

Title: Shinjuro Namiki: Innovator in Amylase Inhibition

Introduction

Shinjuro Namiki is a notable inventor based in Omiya, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of amylase inhibitors. His innovative work has led to advancements in the understanding and application of oligosaccharide substances.

Latest Patents

Namiki holds a patent for "Novel amylase inhibitors." This patent describes the creation of novel oligosaccharide substances, TAI-A and TAI-B, which possess strong inhibitory activity against amylase and invertase. The process involves inoculating a seed of the strain of Streptomyces calvus TM-521 into an aqueous nutrient medium, cultivating it with shaking or through a submerged culture method with aeration, and subsequently separating the produced amylase inhibitors TAI-A and TAI-B from the cultured broth. He has 1 patent to his name.

Career Highlights

Namiki is associated with Taisho Pharmaceutical Co., Ltd., where he continues to contribute to research and development in pharmaceuticals. His work has implications for various applications, including dietary and health-related products.

Collaborations

Some of his notable coworkers include Kunio Kangouri and Takatoshi Nagate. Their collaborative efforts have furthered the research in the field of amylase inhibitors and related substances.

Conclusion

Shinjuro Namiki's innovative contributions to the field of biochemistry, particularly through his patent on amylase inhibitors, highlight his role as a significant inventor. His work continues to influence the pharmaceutical industry and offers potential benefits for health and nutrition.